TickerFactsScreenerDevelopers

Denali Therapeutics Inc. (DNLI) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2016: $39.85M2017: $218.38M2018: $77.12M2019: $79.45M2020: $507.14M2021: $293.48M2022: $218.04M2023: $127.11M2024: $174.96M2025: $205.33M$205.33M
2016Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$205.33M+17.4%
2024$174.96M+37.6%
2023$127.11M-41.7%
2022$218.04M-25.7%
2021$293.48M-42.1%
2020$507.14M+538.3%
2019$79.45M+3.0%
2018$77.12M-64.7%
2017$218.38M+448.0%
2016$39.85M—